Abstract:Pancreatic ductal adenocarcinoma (PDA) has the worst outcome of any solid tumor. Whereas surgical resection remains the mainstay therapy, only 15% of patients present with resectable disease, because of the relationship of the primary tumor to surrounding vasculature. Stereotactic body radiation therapy (SBRT) with simultaneously integrated boost (SIB) to tumor infiltrating blood vessels has the potential to sterilize tissue around the vessels and improve resection rates. Enhancements in accurate tumor imaging and tumor motion assessment would enhance the design of SBRT-SIB. This study reports our early clinical experience with a novel four dimensional magnetic imaging (4DMRI) technique highlighting blood vessels to better characterize motion and individualize boost margins for SBRT-SIB. Seven patients diagnosed with locally advanced PDA were recruited under an IRB protocol. A self-gated k-space sorted 4DMRI based on 3D radial sampling; gradient recalled echo readout and slab-selective excitation was implemented on a 3T scanner. Slab-selective excitation was compared to non-slab-selective excitation to understand the source of the vessel highlight. Patients also received clinical 4DCT. Two contrast-to-noise ratios (CNR), for aorta (CNRAorta) and involved vessel (CNRIV), calculated on non-contrast 4DMRI were compared to those calculated on 4DCT (with delayed oral and intravenous contrasts). The tumor and vessel were contoured on the end-of-exhalation phase for each patient. The 4D image registration was performed using a B-spline based algorithm. The contours were then mapped to the other phases. The geometrical centers of the contours were extracted. Correlation coefficients were calculated comparing tumor and involved vessel motion trajectories in superior-inferior (SI), anterior-posterior (AP), and medial-lateral (ML) directions. All patients were able to complete 4DMRI acquisitions. Compared to non-slab-selective 4DMRI, the slab-selective sequence visually improved contrast of the blood vessels and reduced streaking artifacts. Quantitative analysis showed that the CNRAorta (mean ± σ) improved from 1.9 ± 2.4 to 19.7 ± 13.2 (>9-fold increase) and CNRIV improved from 1.9 ± 1.9 to 12.5 ± 9.2 (>5-fold increase) with non-contrast 4DMRI when comparing to contrast enhanced 4DCT. Correlation coefficients (mean ± σ) for the tumor and vessel motions were 0.95 ± 0.07, 0.78 ± 0.19, and 0.72 ± 0.25 in SI, AP, and ML directions, respectively. A 4DMRI technique highlighting pancreatic tumor infiltrating blood vessels was prospectively evaluated for PDA patients. This non-contrast 4DMRI sequence significantly improved vessel contrast to noise ratio compared to 4DCT performed with delayed intravenous contrast. Tumor motion correlated well with involved vessels in all directions but best in the SI direction. This technique has the potential to more accurately characterize both tumor and boost volume margins for pancreas SBRT-SIB.

SU-E-J-187: Individually Optimized Contrast-Enhancement 4D-CT for Pancreatic Adenocarcinoma in Radiotherapy Simulation.

Comparison of Double Contrast-Enhanced Ultrasound and MDCT for Assessing Vascular Involvement of Pancreatic Adenocarcinoma: Preliminary Results Correlated with Surgical Findings

Chemical Exchange Saturation Transfer for Pancreatic Ductal Adenocarcinoma Evaluation

Contrast enhanced ultrasonography vs.contrast enhanced computed tomography for the diagnosis of focal lesions of the pancreas

Comparative Diagnostic Evaluation with Contrast-Enhanced Ultrasound, Computed Tomography and Magnetic Resonance Imaging in Patients with Pancreatic Cystic Neoplasms

Synchronized Contrast-Enhanced 4DCT Simulation for Target Volume Delineation in Abdominal SBRT

TU-C-213CD-05: 4D-CT Simulation Using Individually Optimized Contrast Enhancement (CE): A Phantom Study

Novel Noncontrast 4D Magnetic Resonance Imaging–Based Imaging of Tumor Infiltrating Vasculature: Improve the Accuracy of Tumor and Boost Volume Motion Characterization for Pancreas SBRT-SIB

Enhancing pancreatic tumor delineation using dual-energy CT-derived extracellular volume fraction map

Optimization of a protocol for contrast-enhanced four-dimensional computed tomography imaging of thoracic tumors using minimal contrast agent

Clinical application of dynamic contrast enhanced ultrasound in monitoring the treatment response of chemoradiotherapy of pancreatic ductal adenocarcinoma

Clinical Value of Dual-energy CT in Detection of Pancreatic Adenocarcinoma: Investigation of the Best Pancreatic Tumor Contrast to Noise Ratio

Consequences of additional use of contrast-enhanced 18F-FDG PET/CT in target volume delineation and dose distribution for pancreatic cancer

Transabdominal Contrast-Enhanced Ultrasonography of Pancreatic Cancer

Helical computed tomography of the pancreas: potential impact of higher concentrated contrast agents and multidetector technology

Assessment of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in the Differentiation of Pancreatic Ductal Adenocarcinoma from Other Pancreatic Solid Lesions.

Pancreatic cancer in photon-counting CT: Low keV virtual monoenergetic images improve tumor conspicuity

Three-dimensional Contrast-enhanced Ultrasound in Response Assessment for Breast Cancer: A Comparison with Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathology.

4D perfusion CT of prostate cancer for image-guided radiotherapy planning: A proof of concept study

Diagnostic Value of Contrast-Enhanced Dual-Energy Computed Tomography in the Pancreatic Parenchymal and Delayed Phases for Pancreatic Cancer

Early Assessment of Chemoradiotherapy Response for Locally Advanced Pancreatic Ductal Adenocarcinoma by Dynamic Contrast-Enhanced Ultrasound